Evidence map›Paper›PMID 42162128›Full record

ArticleScientific reports2026

COVID-19 and suicide in Japan from March 2020 to February 2023.

Quentin Batista, Daisuke Fujii, Taisuke Nakata, Takeki Sunakawa

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Quentin BatistaAmazon Japan Inc., 1-8-1 Shimomeguro, Tokyo, Tokyo, 153-0064, Japan.
Daisuke FujiiInternational Monetary Fund, 700 19th St. NW, Washington, DC, 20431, USA.
Taisuke NakataFaculty of Economics, University of Tokyo, 7-3-1 Hongo, Tokyo, Tokyo, 113-0033, Japan.
Takeki SunakawaDepartment of Economics, Hitotsubashi University, 2-1 Naka, Kunitachi, Tokyo, 186-8601, Japan. takeki.sunakawa@gmail.com.

Funding

JSPS Grant-in-Aid for Scientific Research (KAKENHI) 17K13744JSPS Grant-in-Aid for Scientific Research (KAKENHI) 18K12743JSPS Grant-in-Aid for Scientific Research (KAKENHI) 22H04927
6 · The paper itself

Abstract

We estimate excess mortality due to suicides during the COVID-19 pandemic in Japan and the extent to which the increase in unemployment can explain it. Using a time-series model, as well as pre-COVID private-sector forecasts of the unemployment rate, we find that the COVID-19 crisis increased suicides in Japan by approximately 11,000 from March 2020 to February 2023. Furthermore, the increase in unemployment can account for less than 10 percent of this increase. We also find that the excess deaths due to suicides are skewed towards younger generations and females and that lost years of life expectancy associated with the excess deaths due to suicide are almost as large as those associated with COVID-19 deaths.

Indexed as

COVID-19SuicideFemaleHumansJapanLife ExpectancyPandemicsSARS-CoV-2Unemployment

Identifiers

PMID42162128
PMCPMC13396376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.